학술논문
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse
Document Type
Article
Author
Source
In: British Journal of Haematology . (British Journal of Haematology, August 2022, 198(3):523-527)
Subject
Language
English
ISSN
13652141
00071048
00071048